HomePYXS • NASDAQ
Pyxis Oncology Inc
add
Financials
Income Statement
Revenue
Net Income
Revenue
Net income
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 22.78M | -1.18% |
Net income | -22.00M | -3.77% |
Net profit margin | — | — |
Earnings per share | -0.35 | 0.00% |
EBITDA | -22.25M | 0.30% |
Effective tax rate | — | — |
Balance Sheet
Total Assets
Total Liabilities
Total assets
Total liabilities
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 76.26M | -47.34% |
Total assets | 105.60M | -45.93% |
Total liabilities | 36.83M | -11.54% |
Total equity | 68.78M | — |
Shares outstanding | 62.26M | — |
Price to book | 4.25 | — |
Return on assets | -49.77% | — |
Return on capital | -58.42% | — |
Cash Flow
Net Change in Cash
Net change in cash
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Net income | -22.00M | -3.77% |
Cash from operations | -13.28M | 9.46% |
Cash from investing | 11.47M | 143,487.50% |
Cash from financing | -8.00K | -100.48% |
Net change in cash | -1.81M | 86.07% |
Free cash flow | -4.81M | 20.69% |
Previous close
$4.72
Day range
$4.47 - $4.78
Year range
$0.84 - $4.86
Market cap
282.06M USD
Avg Volume
875.40K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
About
Founded
2018
Headquarters
Website
Employees
44
